2 results match your criteria: "Chongqing Engineering Technology Research Center of Biopharmaceuticals[Affiliation]"
Mol Biol Rep
March 2011
Department of Clinical Microbiology and Immunology, The Third Military Medical University, Chongqing Engineering Technology Research Center of Biopharmaceuticals, Chongqing 400038, China.
Mutants of pertussis toxin (PT) S1 subunit and filamentous hemagglutinin (FHA) type I immunodominant domain from Bordetella pertussis (B. pertussis) are considered to be effective candidate antigens for acellular pertussis vaccines; however, the substantial progress is hampered in part for the lack of a suitable in vitro expression system. In this paper, the gene sequences of a S1 mutant C180-R9K/E129G (mS1) and a truncated peptide named Fs from FHA type I immunodominant domain were linked together and constructed to pET22b expression vector as a fusion gene; after inducing with IPTG, it was highly expressed in E.
View Article and Find Full Text PDFWei Sheng Yan Jiu
March 2007
Department of Clinical Microbiology and Immunology, Third Military Medical University & Chongqing Engineering Technology Research Center of Biopharmaceuticals, Chongqing 400038, China.
Escherichia coli O157 is an important food-borne human pathogen. Separation and identification of this bacterium and further research in molecular level could have important significance. The techniques of separation and identification of E.
View Article and Find Full Text PDF